Absolute Quantification of Fully Customizable Protein Panels Using TrueSignature Targeted Mass Spectrometry

Biognosys’ TrueSignature targeted proteomics platform offers a robust CRO service for precise protein quantification across diverse biological matrices and species, offering several key advantages:

Unmatched specificity
Reference peptides enable simultaneous monitoring of endogenous
targets and internal standards, ensuring assay specificity across diverse
matrices.

Proteotypic peptide selection
Eliminates the need for antibodies, allowing precise monitoring of protein
variants such as mutations, truncations and isoforms.

Multiplexing flexibility
Fully customizable assay panels can accommodate up to 50 targets of
interest.

Application in clinical settings
Automated sample preparation and Good Clinical Practice (GCP)-
compliant workflows ensure suitability for clinical studies.